Kinetic evolution of a diabetogenic CD8+ T cell response

Annals of the New York Academy of Sciences

Volumn 1005, Issue , 2003, Pages 88-97

  Santamaria, Pere ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antigen presenting cell (APC); Cytotoxic T lymphocyte (CTL); Dendritic cell (DC); Major histocompatibility complex (MHC); Nonobese diabetic (NOD); Pancreatic lymph node (PLN); Recombination activating gene (RAG); T cell receptor (TCR); Type 1 diabetes (T1D)

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; APOPTOSIS; CELL ACTIVATION; CELL MATURATION; CONFERENCE PAPER; DENDRITIC CELL; DIABETES MELLITUS; DIABETOGENESIS; DISEASE COURSE; EVOLUTION; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLAMMATION; INSULITIS; KINETICS; MOLECULE; NONHUMAN; PANCREAS ISLET BETA CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 1942539173     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1288.010     Document Type: Conference Paper

References (68)

1. CHRISTIANSON, S., L. SHULTZ & E. LEITER. 1993. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-thy-1a donors. Diabetes 42: 44.
2. BENDELAC, A. et al. 1987. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. J. Exp. Med. 166: 823.
3. MILLER, B.J. et al. 1988. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in non-obese diabetic mice. J. Immunol. 140: 52.
4. YAGI, H. et al. 1992. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur. J. Immunol. 22: 2387.
5. THIVOLET, C. et al. 1991. CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent. J. Immunol. 146: 85.
6. HASKINS, K. & M. MCDUFFIE. 1990. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249: 1433.
7. NAKANO, N. et al. 1991. T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice. J. Exp. Med. 173: 1091.
8. BRADLEY, B. et al. 1992. CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes 41: 1603.
9. DANIEL, D. et al. 1995. Epitope specificity, cytokine production profile, and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056.
10. KATZ, J., C. BENOIST & D. MATHIS. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185.
11. PETERSON, J. & K. HASKINS. 1996. Transfer of diabetes in the NOD-scid mouse by CD4 T cell clones: differential requirement for CD8 T cells. Diabetes 45: 328.
12. MCINERNEY, M., S. RATH & C. JANEWAY. 1991. Exclusive expression of MHC class II proteins on CD45+ cells in pancreatic islets of NOD mice. Diabetes 40: 648.
13. SERREZE, D. & E. LEITER. 1994. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6: 900.
14. WONG, F. et al. 1996. CD8 T cell clones from young NOD islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 T cells. J. Exp. Med. 183: 67.
15. KATZ, J., C. BENOIST & D. MATHIS. 1993. Major histocompatibility complex class I molecules are required for the generation of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23: 3358.
16. WICKER, L. et al. 1994. β2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43: 500.
17. null mice are diabetes and insulitis resistant. Diabetes 43: 505.
18. WANG, B. et al. 1996. The role of CD8+ T-cells in initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26: 1762.
19. GRASER, R.T. et al. 2000. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J. Immunol. 164: 3913.
20. NAGATA, M. et al. 1994. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta cells in NOD mice. J. Immunol. 152: 2042.
21. HAYAKAWA, M. et al. 1991. Morphological analysis of selective destruction of pancreatic beta cells by cytotoxic T lymphocytes in NOD mice. Diabetes 40: 1210.
22. NAGATA, M. & J-W. YOON. 1992. Studies on autoimmunity for T cell-mediated beta cell destruction: distinct difference in the destruction of beta cells between CD4+ and CD8+ T cell clones derived from lymphocytes infiltrating the islets of NOD mice. Diabetes 41: 998.
23. SHIMIZU, J., O. KANAGAWA & E. UNANUE. 1993. Presentation of beta cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. J. Immunol. 151: 1723.
24. SANTAMARIA, P. et al. 1995. Beta cell cytotoxic CD8+ T cells from non-obese diabetic mice use highly homologous T cell receptor alpha chain CDR3 sequences. J. Immunol. 154: 2494.
25. VERDAGUER, J. et al. 1996. Acceleration of spontaneous diabetes in TCRβ-transgenic nonobese diabetic mice by beta cell-cytotoxic CD8+ T cells expressing identical endogenous TCRα chains. J. Immunol. 157: 4726.
26. null nonobese diabetic mice. J. Immunol. 157: 3688.
27. SERREZE, D. et al. 1997. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J. Immunol. 157: 3978.
28. TISCH, R. & H. MCDEVITT. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291.
29. VYSE, T. & J. TODD. 1996. Genetic analysis of autoimmune disease. Cell 85: 311.
30. FENNESSY, M. et al. 1994. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population: Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 37: 937-944.
31. HONEYMAN, M. et al. 1995. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1: 576-582.
32. TAIT, B. et al. 1995. HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus. Hum. Immunol. 42: 116-122.
33. NEJENTSEV, S. et al. 1997. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 46: 1888-1892.
34. NAKANISHI, K. et al. 1999. HLA-A24 and -DQA1*0301 in Japanese insulin-dependent diabetes mellitus: independent contributions to susceptibility to the disease and additive contributions to acceleration of beta cell destruction. J. Clin. Endocrinol. Metab. 84: 3721-3725.
35. BOTTAZZO, G.F. et al. 1985. In situ characterization of autoimmune phenomenon: an expression of HLA molecules in the pancreas of diabetic insulinitis. N. Engl. J. Med. 313: 353-360.
36. HANNINEN, A. et al. 1992. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J. Clin. Invest. 90: 1901.
37. ITOH, N. et al. 1993. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. 153: 1360-1377.
38. SOMOZA, N. et al. 1994. Pancreas in recent onset insulin-dependent diabetes mellitus. J. Immunol. 153: 1360-1377.
39. SIBLEY, R.K. et al. 1985. Recurrent diabetes mellitus in the pancreas iso-and allograft. Lab. Invest. 53: 132-144.
40. SANTAMARIA, P. et al. 1992. CD8+ T cells from isletitis of graft-recurrent type I diabetes are oligoclonal and show restricted TcR usage. Diabetes 41 (suppl. 1): 97A.
41. SANTAMARIA, P. et al. 1992. Isolation and characterization of T lymphocytes infiltrating a human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 41: 53-61.
42. WONG, F. et al. 1999. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 9: 1026-1031.
43. AMRANI, A. et al. 2000. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406: 739-742.
44. VERDAGUER, J. et al. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186: 1663-1676.
45. DILORENZO, T. et al. 1998. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use prevalent T cell receptor α chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95: 12538-12543.
46. UTSUGI, T. et al. 1996. MHC class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta cell-cytotoxic CD8+ T-cell clones in vivo. Diabetes 45: 1121.
47. AMRANI, A. et al. 1999. Perforin-independent beta cell destruction by diabetogenic CD8+ T lymphocytes in transgenic nonobese diabetic mice. J. Clin. Invest. 103: 1201.
48. KAGI, D. et al. 1997. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 186: 989.
49. ANDERSON, B. et al. 1999. Dominant CD8+ T-cell response against a single peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 96: 9311.
50. AMRANI, A. et al. 2001. Expansion of the antigenic repertoire of a single T cell receptor upon T-cell activation. J. Immunol. 167: 655.
51. WILLCOX, B.E. & G.F. GAO. 1999. T cell receptor binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 10: 357.
52. GARBOCZI, D. et al. 1996. Structure of the complex between human T-cell receptor, viral peptide, and HLA-A2. Nature 384: 134.
53. GARCIA, K. et al. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279: 1166.
54. WEDEMAYER, G. et al. 1997. Structural insights into the evolution of an antibody combining site. Science 276: 1665.
55. TRUDEAU, J.D. et al. 2002. Autoreactive T cells in peripheral blood predict development of type 1 diabetes. J. Clin. Invest. In press.
56. STUHLER, G. & P. WALDEN. 1993. Collaboration of helper and cytotoxic T lymphocytes. Eur. J. Immunol. 23: 2279.
57. GREWAL, I., J. XU & R. FLAVELL. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378: 617.
58. ESSEN, D.V., H. KIKUTANI & D. GRAY. 1995. CD40 ligand-transduced co-stimulation of T-cells in the development of helper function. Nature 378: 620.
59. YANG, Y. & J. WILSON. 1996. CD40 ligand-dependent T-cell activation: requirement of B7-CD28 signalling through CD40. Science 273: 1862.
60. GREWAL, I., F.D. ROSA & P. MATZINGER. 1996. Requirement for CD40 ligand in costimulation induction, T-cell activation, and experimental allergic encephalomyelitis. Science 273: 1864.
61. RIDGE, J., F.D. ROSA & P. MATZINGER. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393: 474.
62. BENNETT, S. et al. 1998. Help for cytotoxic T-cell responses is mediated by CD40 signalling. Nature 393: 478.
63. SCHOENBERGER, S. et al. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480.
64. + T-cells dissociated from APC activation. Immunity 16: 719.
65. HEMMI, H. et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740.
66. ZHANG, Y. et al. 2002. In situ beta cell death promotes the priming of diabetogenic cytotoxic T-lymphocytes. J. Immunol. 168: 1466.
67. TRUDEAU, J.D. et al. 2000. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes 49: 1-7.
68. + T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 100: 8384-8388.